Global Puerarin for Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Puerarin for Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Puerarin for Injection is a pharmaceutical product derived from the root of the kudzu plant (Pueraria lobata), traditionally used in Chinese medicine. Puerarin contains bioactive compounds such as isoflavones, particularly puerarin, known for its antioxidant, vasodilatory, and neuroprotective properties. This injectable form of puerarin is used in the treatment of cardiovascular diseases, including coronary artery disease, hypertension, and angina pectoris. It improves blood flow, reduces oxidative stress, and enhances cardiac function, making it beneficial for patients with cardiovascular conditions. Puerarin injections are administered in hospitals and clinics as an adjunct therapy for managing cardiovascular risk factors and preventing cardiovascular events.

According to our (Global Info Research) latest study, the global Puerarin for Injection market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

The industry trend for Puerarin for Injection reflects a growing interest in natural remedies and botanical medicines for cardiovascular health and disease prevention. With a shift towards holistic approaches to healthcare, there's increasing demand for plant-derived therapeutics like puerarin that offer cardiovascular benefits with potentially fewer side effects compared to conventional medications. Pharmaceutical companies are investing in research and development to explore the pharmacological properties and therapeutic applications of puerarin and its derivatives in cardiovascular medicine. Additionally, there's a focus on developing standardized formulations and quality control measures to ensure the safety, efficacy, and reproducibility of puerarin injections, driving their integration into evidence-based treatment protocols for cardiovascular diseases.

This report is a detailed and comprehensive analysis for global Puerarin for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Puerarin for Injection market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030

Global Puerarin for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030

Global Puerarin for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030

Global Puerarin for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Puerarin for Injection

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Puerarin for Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Procurenet, Actiza Pharmaceutical, Chengdu Tiantai Mountain Pharmaceutical, You Care, Harbin Sanlian Pharmaceutical, Beijing Sihuan Kebao Pharmaceutical, Hubei Tianyao Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Puerarin for Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
0.1g
0.2g
Others

Market segment by Application
Hospital
Clinic

Major players covered
Procurenet
Actiza Pharmaceutical
Chengdu Tiantai Mountain Pharmaceutical
You Care
Harbin Sanlian Pharmaceutical
Beijing Sihuan Kebao Pharmaceutical
Hubei Tianyao Pharmaceutical

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Puerarin for Injection product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Puerarin for Injection, with price, sales quantity, revenue, and global market share of Puerarin for Injection from 2019 to 2024.

Chapter 3, the Puerarin for Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Puerarin for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Puerarin for Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Puerarin for Injection.

Chapter 14 and 15, to describe Puerarin for Injection sales channel, distributors, customers, research findings and conclusion.